Within PDAC TIL, CD39 was seen to be expressed on up to 27% (median: 11%) of the CD103+ CD8+ TIL population, potentially indicating a substantial tumor-specific T-cell pool (Fig. 3G). The gene discussed is ENTPD1; the disease is neoplasm.